- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 473/36 - Atome de soufre
Détention brevets de la classe C07D 473/36
Brevets de cette classe: 19
Historique des publications depuis 10 ans
|
1
|
3
|
0
|
1
|
1
|
0
|
1
|
0
|
2
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2713 |
2 |
| Vironova Thionation AB | 5 |
2 |
| Changzhou Longthera Pharmaceuticals Inc | 2 |
2 |
| Boehringer Ingelheim International GmbH | 4487 |
1 |
| Ecolab USA Inc. | 5807 |
1 |
| UCB Pharma S.A. | 212 |
1 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3002 |
1 |
| The University of Tokyo | 4372 |
1 |
| Vitae Pharmaceuticals, Inc. | 87 |
1 |
| Zenyaku Kogyo Kabushiki Kaisha | 18 |
1 |
| Agc, Inc. | 5557 |
1 |
| Dcam Pharma Inc | 1 |
1 |
| Livo (Shanghai) Pharmaceutical Co., Ltd | 1 |
1 |
| Micar Innovation Ltd. | 3 |
1 |
| Suzhou Splendus Therapeutics Limited | 1 |
1 |
| Gacter Inc. | 2 |
1 |
| Autres propriétaires | 0 |